OTC - ACTIVE INGREDIENT SECTION
Active ingredient: Ginsenoside Compound K 50 mg/ 10 g
Active ingredient: Ginsenoside Compound K 50 mg/ 10 g
Purpose: Regulate the human immune system; Treat tuberculosis
Warnings:
Do not use if you are allergic to this product and its ingredients
Ask a doctor before use if you have
Other diseases;
Or take some medicines
Ask a doctor or pharmacist before use if you are Pregnant women Or infants
When using this product:
Take before meals,
Take it half an hour before going to bed
Stop use and ask a doctor if There was no sign of relief after taking for 4 weeks.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Directions:
Take one bottle orally with water, three times daily.
For internal use only.
Inactive ingredients: CORN STAREH, YEAST. BETA. -D-GLUCAN, URSOLIC ACID
Questions? 123-555-1234
Other information:
Store at 5-30℃,
Keep out of direct sunlight
Use: Regulate the human immune system; Treat tuberculosis
When using this productTake before mealsTake it half an hour before going to bed
See Label
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 84428-103-01 | Tuberculosis Eliminator | 50 g in 1 BOTTLE | GRANULE | 50 | 1 | |
| 84428-103-02 | Tuberculosis Eliminator | 7 in 1 BOX | GRANULE | 7 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 84428-103 | 84428-103-01, 84428-103-02 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| YEAST .BETA.-D-GLUCAN | 44FQ49X6UN | IACT |
| STARCH, CORN | O8232NY3SJ | IACT |
| URSOLIC ACID | P3M2575F3F | IACT |
| GINSENOSIDE COMPOUND K | G8D4792Q7K | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 2eb5926c-e9dd-59f9-e063-6294a90aae44 | 2eb59817-cf1f-4b22-e063-6394a90a05db | 2025-02-22 | Warnings | 2eb5926c-e9dd-59f9-e063-6294a90aae44 2eb59817-cf1f-4b22-e063-6394a90a05db |
Adverse event summaries are temporarily unavailable. Other product information remains available.